-
Increasing the use of mobile technology-derived endpoints in clinical trials.
Journal article
Herrington WG. et al, (2018), Clinical trials (London, England), 1740774518755393 - 1740774518755393
-
Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Conference paper
Gray R. et al, (2018), CANCER RESEARCH, 78
-
Research digest: progress in microvascular complications
Journal article
Sattar N. and Preiss D., (2018), The Lancet Diabetes and Endocrinology, 6
-
Challenges in Interpreting Multivariable Mendelian Randomization: Might "Good Cholesterol" Be Good After All?
Journal article
Holmes MV. and Davey Smith G., (2018), Am J Kidney Dis, 71, 149 - 153
-
Risk factors for upgrading and upstaging of pre-operative biopsies in ductal carcinoma in situ
Conference paper
Mannu GS. et al, (2018), CANCER RESEARCH, 78
-
Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.
Journal article
Richards SH. et al, (2018), European journal of preventive cardiology, 25, 247 - 259
-
A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?
Journal article
Tenaerts P. et al, (2018), Clin Trials, 15, 5 - 12
-
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.
Journal article
Parish S. et al, (2018), Circ Genom Precis Med, 11
-
Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
Journal article
Hopewell JC. et al, (2018), European Heart Journal
-
The Role of Lipoprotein(a) in Chronic Kidney Disease.
Journal article
Hopewell JC. et al, (2018), Journal of lipid research